Search

Your search keyword '"Varizhuk A"' showing total 400 results

Search Constraints

Start Over You searched for: Author "Varizhuk A" Remove constraint Author: "Varizhuk A"
400 results on '"Varizhuk A"'

Search Results

201. Synthesis of Triazole-Linked Oligonucleotides with High Affinity to DNA Complements and an Analysis of Their Compatibility with Biosystems

209. Oligonucleotide analogues containing a C3′-NH-C(O)-CH2-C5′ amide internucleotide bond.

210. Synthesis of 5′-deoxy-5′-ethoxycarbonylmethyl nucleosides, the precursors of oligonucleotides with the amide internucleoside bond C3′-NH-C(O)-CH2-C5′.

211. Oligonucleotide analogues containing internucleotide C3′-CH2-C(O)-NH-C5′ bonds.

212. Synthesis of 3′-deoxy-3′-carboxymethylnucleosides, precursors of oligonucleotides with an amide internucleoside bond.

214. Oligonucleotide analogues containing internucleotide C3'-CH2-C(O)-NH-C5' bonds

220. Oligonucleotide analogues containing a C3'-NH-C(O)-CH(2)-C5' amide internucleotide bond

221. Production and Characterization of Photorin, a Novel Proteinaceous Protease Inhibitor from the Entomopathogenic Bacteria Photorhabdus laumondii.

222. Alpha-Deoxyguanosine to Reshape the Alpha-Thrombin Binding Aptamer.

223. G-Quadruplexes in Nuclear Biomolecular Condensates.

224. NMR structure of emfourin, a novel protein metalloprotease inhibitor: Insights into the mechanism of action.

225. Modeling G4s in chromatin context confirms partial nucleosome exclusion and reveals nucleosome-disrupting effects of the least selective G4 ligands.

226. Nucleoside Analogs and Perylene Derivatives Modulate Phase Separation of SARS-CoV-2 N Protein and Genomic RNA In Vitro.

227. cNTnC and fYTnC2, Genetically Encoded Green Calcium Indicators Based on Troponin C from Fast Animals.

228. Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern.

229. Anticancer activity of G4-targeting phenoxazine derivatives in vitro.

230. Diversifying i-motif-based pH sensors: Labeling patterns tune the intracellular localization.

231. Cytotoxicity reduction by O-nicotinoylation of antiviral 6-benzylaminopurine ribonucleosides.

232. Autoimmune Effect of Antibodies against the SARS-CoV-2 Nucleoprotein.

233. DNA Intercalated Motifs with Non-Nucleoside Inserts.

234. Phenoxazine pseudonucleotides in DNA i-motifs allow precise profiling of small molecule binders by fluorescence monitoring.

235. Thiadiazole-, selenadiazole- and triazole-fused anthraquinones as G-quadruplex targeting anticancer compounds.

236. Transcription-facilitating histone chaperons interact with genomic and synthetic G4 structures.

237. DNA complexes with Ni nanoparticles: structural and functional properties.

238. DNA G-Quadruplexes Contribute to CTCF Recruitment.

239. Genomic DNA i-motifs as fast sensors responsive to near-physiological pH microchanges.

240. Efficient silica synthesis from tetra(glycerol)orthosilicate with cathepsin- and silicatein-like proteins.

241. NTnC-like genetically encoded calcium indicator with a positive and enhanced response and fast kinetics.

242. Genetically encoded calcium indicator with NTnC-like design and enhanced fluorescence contrast and kinetics.

243. Synthesis and Biological Evaluation of Benzo [4,5]- and Naphtho[2',1':4,5]imidazo[1,2-c]pyrimidinone Derivatives.

244. Unwinding the SARS-CoV-2 Ribosomal Frameshifting Pseudoknot with LNA and G-Clamp-Modified Phosphorothioate Oligonucleotides Inhibits Viral Replication.

245. Phenotypic Test of Benzo[4,5]imidazo[1,2-c]pyrimidinone-Based Nucleoside and Non-Nucleoside Derivatives against DNA and RNA Viruses, Including Coronaviruses.

246. Genome-Wide Transcriptional Response of Mycobacterium smegmatis MC 2 155 to G-Quadruplex Ligands BRACO-19 and TMPyP4.

247. 16S rRNA gene sequencing data of the upper respiratory tract microbiome in the SARS-CoV-2 infected patients.

248. EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus.

249. Aureolic Acid Group of Agents as Potential Antituberculosis Drugs.

250. G4 Aptamers: Trends in Structural Design.

Catalog

Books, media, physical & digital resources